Location History:
- Alpharetta, GA (US) (2006 - 2010)
- Germantown, MD (US) (2006 - 2012)
Company Filing History:
2 out of 1,036 
1 out of 549 
1 out of 28 
Years Active: 2006-2012
Title: The Innovative Contributions of Kimberly A. Hunsucker
Introduction
Kimberly A. Hunsucker is a notable inventor based in Germantown, MD, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to her name, she has focused her research on the synthesis of important compounds that have potential therapeutic applications.
Latest Patents
Hunsucker's latest patents include the "Synthesis of 4-amino-thalidomide enantiomers." This invention provides new and useful analogs of 4-amino-thalidomide, specifically S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also outlines processes for making these analogs. Furthermore, it presents methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds. Another patent, titled "Method of synthesis of 4-amino-thalidomide enantiomers," shares similar innovations and applications.
Career Highlights
Throughout her career, Hunsucker has worked with reputable organizations such as Children's Medical Center Corporation and Celgene Corporation. Her experience in these companies has allowed her to develop her expertise in pharmaceutical research and innovation.
Collaborations
Hunsucker has collaborated with notable colleagues, including Jamshed H. Shah and Anthony Treston. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Kimberly A. Hunsucker's work in synthesizing 4-amino-thalidomide enantiomers showcases her innovative spirit and dedication to improving medical treatments. Her contributions to the field of pharmaceuticals are commendable and highlight the importance of research in addressing critical health issues.